image: Researchers have developed an antibody that prevents blood clots without causing bleeding, a risk associated with current anticoagulant drugs. This material relates to a paper that appeared in the Aug. 24, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by T. David at University of California, San Francisco in San Francisco, CA, and colleagues was titled, 'Factor XIa-specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis.' view more
Credit: Chris Bickel / <i>Science Translational Medicine</i> (2016)